TCL Archive BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal June 21, 2002
TCL Archive Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products. October 8, 2004
TCL Archive In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin April 22, 1977
